Trial Profile
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Pharmacokinetics of Single and Multiple Ascending Doses and Effect of Food on the Pharmacokinetics of DM1157 in Healthy Adults
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 23 Feb 2022
Price :
$35
*
At a glance
- Drugs DM-1157 (Primary)
- Indications Malaria
- Focus Adverse reactions; First in man; Pharmacokinetics
- 20 Feb 2022 Results published in the Infectious Diseases and Therapy
- 14 Nov 2019 Status changed from suspended to discontinued.
- 13 Jun 2019 Planned End Date changed from 4 Jun 2019 to 4 Sep 2019.